Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume – Still a Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw an uptick in trading volume on Friday . 1,164,778 shares traded hands during mid-day trading, an increase of 161% from the previous session’s volume of 445,557 shares.The stock last traded at $6.62 and had previously closed at $6.6650.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

Coloplast A/S Trading Down 1.1%

The company’s 50 day simple moving average is $7.90 and its two-hundred day simple moving average is $8.65. The company has a market cap of $14.85 billion, a PE ratio of 24.41, a price-to-earnings-growth ratio of 0.69 and a beta of 0.33. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. As a group, sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.